Diamond Princess cruise ship, site of mass COVID outbreak, returns to service after nearly 3 years

The Diamond Princess cruise ship returned to the seas on Sunday for the first time since the vessel saw a widespread COVID-19 outbreak in early 2020 — an event that precipitated the global shutdown of the cruise industry.
USA Today reported that the ship, which is owned by Princess Cruises, left its new homeport of San Diego for a week-long embarkation to Mexico. The ship had been based in Japan prior to the pandemic.
In a press release, Princess Cruises said the ship will also embark on a number of other itineraries through Feburary 2023. This includes stops along the coast of California, the Hawaiian Islands, and Central America.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This trip marks the first time the Diamond Princess is welcoming passengers since a mass outbreak on the ship in Japan in February 2020 put the dangers of COVID-19 on the map. The New York Times has previously reported on the devastating effects of the virus on the ship's passengers. The outbreak reportedly began with just a single infected person who boarded the ship; by the next month, more than 700 of the 3,711 people on the Diamond Princess were sick.
The rapid spread of the virus forced those onboard to quarantine for nearly a month, as COVID-19 continued to wreak havoc through the ship. One Japanese scientist described the conditions during the quarantine as "completely inadequate in terms of infection control." He noted that there was no distinction between contaminated and infection-free zones, saying the ship "[violated] all infection control principles."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
How to figure out when your tax refund will arrive
The explainer How long do you have to wait between submitting your return and receiving the money?
By Becca Stanek, The Week US Published
-
'It also means the start of a virtuous ecological cycle'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Canada beats US in charged 4 Nations hockey final
Speed Read 'You can't take our country — and you can't take our game,' Prime Minister Justin Trudeau posted after the game
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published